Biological and Environmental Research Ontology

Last uploaded: December 23, 2022
Id http://purl.obolibrary.org/obo/NCIT_C2550
http://purl.obolibrary.org/obo/NCIT_C2550
Preferred Name

Palladium Pd-103
Definitions
A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-energy irradiation to the tumor cell population while sparing normal adjacent tissues from radiotoxicity. (NCI04)
Type http://www.w3.org/2002/07/owl#Class

All Properties

definition

A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-energy irradiation to the tumor cell population while sparing normal adjacent tissues from radiotoxicity. (NCI04)
prefLabel
Palladium Pd-103
label
Palladium Pd-103
PDQ_Closed_Trial_Search_ID
38046
code
C2550
prefixIRI
NCIT:C2550
in_subset
Display_Name
Palladium Pd-103
Preferred_Name
Palladium Pd-103
FDA_UNII_Code
68QTV136DF
Contributing_Source
CTRP
FDA
Maps_To
Palladium Pd-103
CAS_Registry
14967-68-1
NCI_Drug_Dictionary_ID
38046
Legacy Concept Name
Palladium_103
type
ALT_DEFINITION
A radioactive form of palladium (a metallic element that resembles platinum). When used to treat prostate cancer, radioactive seeds (small pellets that contain radioactive palladium) are placed in the prostate. Cancer cells are killed by the energy given off as the radioactive material breaks down and becomes more stable.
Is_Value_For_GDC_Property
subClassOf
PDQ_Open_Trial_Search_ID
38046
Accepted_Therapeutic_Use_For
Early Stage Prostate Cancer; Localized Tumours of the Head, Neck, Lung, Pancreas, Breast, Intraocular and Uterus.
Semantic_Type
Element, Ion, or Isotope
UMLS_CUI
C0303566
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display